Linagliptin Chloro Impurity

Linagliptin Chloro Impurity is a structurally related synthetic byproduct arising from chlorination during the parent drug's synthesis. It features a 3-chloro substitution on the naphthalene ring of linagliptin, retaining the pyrazine-tetrahydropyridine core but with altered electronic properties due to the electron-withdrawing chloro group. This impurity serves as a critical HPLC reference standard for quantifying chlorinated process impurities in linagliptin active pharmaceutical ingredient (API) batches.